| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.4 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.04 | 0.4 |